Stockreport

Arca Biopharma Nearly Quintuples On Plans To Test A Coronavirus Drug [Investor's Business Daily]

ARCA biopharma, Inc.  (ABIO) 
US:NASDAQ Investor Relations: arcabio.com/investors
PDF Shares of Arca Biopharma nearly quintupled in value Thursday after the biotech company announced it would develop a coronavirus treatment for patients with abnormal bloo [Read more]